Serum metabolomics study on colorectal cancer by ESI (±)-FTICR MS
(0) Colorectal cancer (CRC) has attracted an increasing attention due to its common worldwide distribution and leading cause of death. Metabolomics, which is characterized by a large number of molecules exhibiting a high diversity of chemical structures and abundances, is currently being used as a mode of research in many disciplines of medicine. With accurate mass measurement with even sub-ppm errors and also ultra-high resolving power, FTICR MS has become a popular analytical platform. This study contributed to reveal some metabolomics perturbation in CRC patients by ESI ( ± )-FTICR MS to assist the interpretation of physiopathological mechanism of this disease and maybe aid in future clinical diagnosis.
serum metabolomics colorectal cancer FTICR MS OPLS
Fang Li Yumei Guo Hui Liu Fenjie Li Zhili Li
Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Pe
国内会议
呼和浩特
英文
213-213
2011-07-20（万方平台首次上网日期，不代表论文的发表时间）